Skip to content
Tenfell
Awarded contract
Published 28 May 2026

NHS Generic Pharmaceuticals - Lenalidomide, Pomalidomide & Thalidomide

NHS England · London

Key facts

Awarded
12 Apr 2026
Contract starts
31 May 2026
Contract ends
31 May 2028
Procedure
Open procedure (framework)
Buyer type
Central government

Awarded to 10 suppliers

SupplierValue
Teva UK Ltd—
Viatris UK Healthcare Ltd—
Thornton & Ross Ltd—
Wockhardt UK Limited—
Accord-UK Ltd—
Sun Pharma UK Ltd—
Zentiva Pharma UK Ltd—
Amarox Limited—
Milpharm Limited—
Lipomed AG—

Description

NHS National Framework for Lenalidomide, Pomalidomide & Thalidomide. Offer reference number: CM/PHG/24/5716 Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) for a period or periods up to a total of 48 months. Periods of call-offs under the framework agreement: CM/PHG/24/5716/01– NHS National Framework for Lenalidomide, Pomalidomide & Thalidomide. CESW: (Midlands and Southwest): 1st June 2026 – 31st May 2028 NWLN: (Northwest and London North): 1st June 2026 – 31st May 2028 LSNE: (London South and Northeast): 1st June 2026 – 31st May 2028

Categories (CPV)

Similar open tenders

About NHS England

Their tenders, awards, contracts coming up for renewal, decision makers and committee papers.

View buyer profile

Their other open tenders

Published by the buyer on Find a Tender (Open Government Licence v3.0). Always read the original notice before responding.